Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LLY    crawled time : 12:39    save search
Lilly's bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19
Published: 2021-03-10 (Crawled : 12:39) - biospace.com/
LLY | News | $732.2 -1.81% -0.84% 1.7M twitter stocktwits trandingview |
Health Technology
 | | O: 0.38% H: 0.56% C: -0.69%
covid phase 3 trial
Gainers vs Losers
61% 39%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services
BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services
WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services
AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services
WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information
Your saved searches
Save your searches and get alerts when important news are released.